DE:L8S / Grace Therapeutics, Inc. - Net Long/Short Value

Grace Therapeutics, Inc.
DE ˙ DB
€ 47.60 ↑0.49 (1.03%)
2014-01-31
BAHAGING PRESYO
DE:L8S / Grace Therapeutics, Inc. - Net Long/Short Value
Halaman ini menyediakan nilai bersih long/short untuk setiap kepemilikan institusional yang dilaporkan melalui pengajuan 13F atau NPORT. Untuk menghitung nilai bersih long/short, kami menambahkan nilai ekuitas ke nilai opsi beli (call option) dan mengurangi nilai opsi jual (put option). Dana yang melaporkan posisi short-borrowed akan melaporkan nilai ekuitas sebagai negatif. Posisi long bersih akan memiliki angka positif di kolom long/short bersih, dan posisi short bersih akan memiliki nilai negatif di kolom tersebut.
Pemilik Nilai Ekuitas
($1000)
Nilai Panggilan
($1000)
Masukkan Nilai
($1000)
Posisi Long/Short Bersih
($1000)
FNCMX - FIDELITY CONCORD STREET TRUST - Fidelity Nasdaq Composite Index Fund
Nantahala Capital Management, LLC
Royal Bank Of Canada
Renaissance Technologies Llc
Bank Of America Corp /de/
Citigroup Inc
Millington Financial Advisors, LLC
Citadel Advisors Llc
Morgan Stanley
VTSMX - VANGUARD INDEX FUNDS - Vanguard Total Stock Market Index Fund Investor Shares
National Bank Of Canada /fi/
Palumbo Wealth Management LLC
ADAR1 Capital Management, LLC
Stonepine Capital Management, LLC
Vanguard Group Inc
Jones Financial Companies Lllp
Federation des caisses Desjardins du Quebec
Steward Partners Investment Advisory, Llc
AIGH Capital Management LLC
SBI Securities Co., Ltd.
Tower Research Capital LLC (TRC)
Activest Wealth Management
Other Listings
US:GRCE US$ 3.24
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista